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Summary: Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of mortality and morbidity world 
wide. Due to lack of awareness about the precipitating factors and predictors of prognosis, cases of acute exacerbation of 
COPD often suffer the fatal outcomes. In our study we assessed the levels of serum sodium and potassium in subjects with 
acute episodes of COPD and their healthy controls. We found a significantly low level of serum sodium (133 ± 6.86 
meq/lit) and potassium (3.39 ± 0.96 meq/lit)) in subjects with acute exacerbation of COPD than their healthy counterparts 
[sodium-142 ± 2.28 meq/lit and potassium- 4.52 ± 0.02 meq/lit (p<0.05)]. Therefore, our study findings suggest that, serum 
sodium and potassium levels may get deranged in subjects with acute exacerbations of COPD which should be routinely 
checked for to avoid fatal outcomes.  
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Chronic Obstructive Pulmonary Disease (COPD) is 
the sixth leading cause of death and therefore a 
disease of increasing public health importance around 
the world. Estimations of Global Initiative for 
Chronic Obstructive Lung Disease (GOLD) suggest 
that COPD will rise to the third most common cause 
of death worldwide by 2020 (Reilly J, 2005). 
 Not only a leading cause of death, following an 
acute exacerbation of COPD, majority of the patients 
experience a temporary or permanent decrease in the 
quality of life. Moreover, more than half the patients 
discharged, often require re-admission in the 
subsequent six months (Mohan et al, 2006). Thus, the 
economic and social burden created by acute 
execrations of COPD are extremely high. In spite of 
such alarming outcomes, very less data are available 
there regarding the precipitating factors and 
predictors of prognosis in patients with acute 
exacerbation of COPD especially from the developing 
countries. 
 Though the COPD patients mostly present with 
the  features of acute respiratory infections ( 
productive cough, dyspnoea etc.), there may be a 
number of metabolic derangements arising out of the 
disease process or as a consequence of the therapy 
instituted like hyponatremia, hypokalemia, 
hyperbilirubinemia , elevated transaminases, elevated 
blood urea and elevated serum creatinine etc (Mohan 
et al,2006). Though most of these features are 
correctable, very often they are missed or confuse the 
diagnosis. Thus simple overlooking of the coexistent 
metabolic abnormalities may contribute to a great 
deal of mortality and morbidity in the COPD patients.  
 With this background, in the present study we 
attempted to measure the concentration of major 
serum electrolytes (sodium, potassium) in COPD 
patients with acute exacerbation and compare those 
finding with that of normal healthy controls to verify 
the occurrence of dyselectrolytemia in the said group 
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of patients which may be one of the major risk factors 
for increased mortality and morbidity in them. 
 
MATERIAL & METHODS 
 
Study was conducted on 64 patients of acute 
exacerbation of COPD from the Department of 
Medicine at Medical College and Hospital, Kolkata 
and 20 age- sex matched healthy community control. 
All the tests were done with due permission from the 
Institutional Ethical Committee and informed consent 
from the subjects or their legal relatives. 
 Subjects were included on the basis of their 
diagnosis of COPD by the attending physicians. 
Unrelated causes of dyselectrolytemia other than 
COPD or its management like known cases of chronic 
renal failure, diabetic ketoacidosis, adrenocortical 
insufficiency, cerebral salt wasting were excluded 
from the study. Disease free 20 healthy volunteers 
from the community were examined as controls. 
 Fasting blood samples from all the subjects were 
collected for the estimation of serum electrolytes like 
sodium and potassium in auto analyzer (Easylyte 
plus- sodium, potassium, chloride analyzer, Medica 
Corporation, USA. Kit used was supplied by the same 
company.)  at the clinical laboratory of Medical 
College and Hospital, Kolkata.  
 Data were analyzed by STATA 10 and Microsoft 
Excel software. Significance of differences of average 
sodium and potassium levels in two groups were 
evaluated statistically using Student’s’ test. (p- Value 




Total 64 patients of COPD (47 males and 17 females) 
and 20 age sex matched healthy controls (15 males 
and 5 females) were investigated. Subjects of COPD 
were in the age range of 40-78 years, average age of 
presentation being 62.22 ± 12.45 years. In the control 
group, subjects were in the age range of 40- 78 years, 
average age being 61 ± 10.5 years. Average serum 
sodium and potassium levels in COPD patients were 
133 ± 6.86 meq/lit and 3.39 ± 0.96 meq/lit 
respectively. The above levels in the control group 
were 142 ± 2.28 mEq/lit and 4.52 ± 0.02 meq/lit 





Reliable epidemiological data regarding the clinical 
presentation and outcome of acute execerbations of 
COPD are grossly lacking from the developing 
countries. It has been observed that besides the signs 
of acute infection, there may be number of co-morbid 
conditions like type II respiratory failure and carbon 
dioxide narcosis, metabolic abnormalities such as 
dyselectrolytemia, uremia and hepatic function 
derangement etc. Though most of them are 
correctable, active attempt often can not be made 
either due to overlooking or due to unavailability of 
facilities for round-the-clock laboratory monitoring. 
In our study we attempted to measure the major 
electrolyte levels (sodium and potassium) in patients 
of COPD with acute exacerbation ( except the 
subjects with exclusion criteria). We found a 
significantly low level of serum sodium and 
potassium in the COPD patients than that of the 
healthy controls (p- value < 0.05 in each case). 
 
Table 1:  












COPD  62.22 
± 
12.45 




control 61  
± 10.5 




*-Values are significantly different from the control group 
(p<0.05). 
 
 Patients with COPD are susceptible to 
hyponatremia for a number of reasons. Chronic 
hypoxia and hypercapnia secondary to the underlying 
pulmonary illness, heart failure or renal insufficiency, 
use of diuretics, SIADH (Syndrome of Inappropriate 
Antidiuretic Hormone Synthesis), use of 
bronchodilators or steroids, malnutrition, and poor 
intake during acute exacerbations are common 
contributing factors for hyponatremia in such 
patients. Activation of the renin-angiotensin-
aldosterone system and inappropriately elevated 
plasma arginine vasopressin (AVP) in COPD may 
cause hyponatremia (Bauer et al, 1965).  Irrespective 
of the underlying mechanism of development, 
hyponatremia itself may be a predictor of poor 
outcome in patients of COPD. It may lead to central 
nervous system dysfunction; confusion, convulsions, 
coma, reversible cardiac conduction defect, secondary 
renal insufficiency even death (Suri et al, 2009; 
Porcel et al, 2002). Therefore, hyponatremia should 
be meticulously searched for in every patient with 
acute exacerbation of COPD and should be actively 
tackled at the earliest. 
 Along with hyponatremia, hypokalemia may be 
another morbid accompaniment in the subjects with 
COPD. Hypokalemia may be present independently 
or concomitantly with hyponatremia. In our study 
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there was a significantly low level of serum 
potassium in COPD patients than the healthy controls. 
Hypokalemia in COPD may be attributed to 
respiratory acidosis and metabolic alkalosis or long 
standing steroid therapy (Saini et al, 2008). Use of 
beta 2-adrenoceptor agonists like fenoterol or 
salbutamol may also contribute to hypokalemia in 
COPD patients (Yang  et al, 1998). Moreover, acute 
respiratory failure associated with hypokalemia was 
found to have a high mortality rate among the COPD 
patients (Hussain et al, 2008). High mortality in  
hypokalemia may be attributed to cardiac arrhythmias 
or hampered nerve-muscle conduction. So, it appears 
from our study that hypokalemia may be a common 
associated finding in the subjects with COPD that 
should be corrected promptly to avoid fatal outcomes. 
 In conclusion, Serum sodium and potassium levels 
may get deranged in subjects with acute exacerbation 
of COPD. So, these levels should be monitored 
routinely in those patients and attempt should be 
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